However, in studies involving different gliomas, Pekmezci et al. (2017) revealed that the wild‐type TERTp group was associated with a good prognosis only in wild‐type IDH1/IDH2 and the TERTp and IDH co‐altered group also had a better prognosis than found in the IDH mutation group. The gene discussed is IDH1; the disease is central nervous system cancer.